ExpreS2ion Biotech (Sweden) Buy Hold or Sell Recommendation
| EXPRS2 Stock | SEK 2.78 0.06 2.21% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding ExpreS2ion Biotech Holding is 'Strong Sell'. Macroaxis provides ExpreS2ion Biotech buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding EXPRS2 positions. The advice algorithm takes into account all of ExpreS2ion Biotech's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting ExpreS2ion Biotech's buy or sell advice are summarized below:
Real Value 2.34 | Hype Value 2.78 | Market Value 2.78 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell ExpreS2ion Biotech Holding given historical horizon and risk tolerance towards ExpreS2ion Biotech. When Macroaxis issues a 'buy' or 'sell' recommendation for ExpreS2ion Biotech Holding, the advice is generated through an automated system that utilizes algorithms and statistical models.
ExpreS2ion |
Execute ExpreS2ion Biotech Buy or Sell Advice
The ExpreS2ion recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ExpreS2ion Biotech Holding. Macroaxis does not own or have any residual interests in ExpreS2ion Biotech Holding or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ExpreS2ion Biotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
ExpreS2ion Biotech Trading Alerts and Improvement Suggestions
| ExpreS2ion Biotech generated a negative expected return over the last 90 days | |
| ExpreS2ion Biotech has high historical volatility and very poor performance | |
| The company reported the revenue of 12.23 M. Net Loss for the year was (43.92 M) with profit before overhead, payroll, taxes, and interest of 1.07 M. | |
| ExpreS2ion Biotech Holding has accumulated about 10.14 M in cash with (45.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.75. |
ExpreS2ion Biotech Returns Distribution Density
The distribution of ExpreS2ion Biotech's historical returns is an attempt to chart the uncertainty of ExpreS2ion Biotech's future price movements. The chart of the probability distribution of ExpreS2ion Biotech daily returns describes the distribution of returns around its average expected value. We use ExpreS2ion Biotech Holding price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ExpreS2ion Biotech returns is essential to provide solid investment advice for ExpreS2ion Biotech.
| Mean Return | -0.19 | Value At Risk | -6.12 | Potential Upside | 4.69 | Standard Deviation | 5.05 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ExpreS2ion Biotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ExpreS2ion Biotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ExpreS2ion Biotech or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ExpreS2ion Biotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ExpreS2ion stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.18 | |
β | Beta against NYSE Composite | -0.27 | |
σ | Overall volatility | 5.05 | |
Ir | Information ratio | -0.06 |
ExpreS2ion Biotech Volatility Alert
ExpreS2ion Biotech Holding exhibits very low volatility with skewness of 3.13 and kurtosis of 17.72. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ExpreS2ion Biotech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ExpreS2ion Biotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ExpreS2ion Biotech Fundamentals Vs Peers
Comparing ExpreS2ion Biotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ExpreS2ion Biotech's direct or indirect competition across all of the common fundamentals between ExpreS2ion Biotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as ExpreS2ion Biotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ExpreS2ion Biotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing ExpreS2ion Biotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ExpreS2ion Biotech to competition |
| Fundamentals | ExpreS2ion Biotech | Peer Average |
| Return On Equity | -0.97 | -0.31 |
| Return On Asset | -0.55 | -0.14 |
| Operating Margin | (20.75) % | (5.51) % |
| Current Valuation | 361.15 M | 16.62 B |
| Shares Outstanding | 37.15 M | 571.82 M |
| Shares Owned By Institutions | 1.75 % | 39.21 % |
| Price To Book | 3.42 X | 9.51 X |
| Price To Sales | 55.94 X | 11.42 X |
| Revenue | 12.23 M | 9.43 B |
| Gross Profit | 1.07 M | 27.38 B |
| EBITDA | (45.5 M) | 3.9 B |
| Net Income | (43.92 M) | 570.98 M |
| Cash And Equivalents | 10.14 M | 2.7 B |
| Cash Per Share | 0.75 X | 5.01 X |
| Total Debt | 3.48 M | 5.32 B |
| Debt To Equity | 10.40 % | 48.70 % |
| Current Ratio | 2.62 X | 2.16 X |
| Book Value Per Share | 2.75 X | 1.93 K |
| Cash Flow From Operations | (45.65 M) | 971.22 M |
| Earnings Per Share | (1.55) X | 3.12 X |
| Number Of Employees | 14 | 18.84 K |
| Beta | 1.25 | -0.15 |
| Market Capitalization | 487.85 M | 19.03 B |
| Total Asset | 151.96 M | 29.47 B |
| Z Score | 84.0 | 8.72 |
| Net Asset | 151.96 M |
ExpreS2ion Biotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ExpreS2ion . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About ExpreS2ion Biotech Buy or Sell Advice
When is the right time to buy or sell ExpreS2ion Biotech Holding? Buying financial instruments such as ExpreS2ion Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ExpreS2ion Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Latest Losers Thematic Idea Now
Latest Losers
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Losers theme has 212 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Losers Theme or any other thematic opportunities.
| View All Next | Launch |
Check out ExpreS2ion Biotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for ExpreS2ion Stock analysis
When running ExpreS2ion Biotech's price analysis, check to measure ExpreS2ion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ExpreS2ion Biotech is operating at the current time. Most of ExpreS2ion Biotech's value examination focuses on studying past and present price action to predict the probability of ExpreS2ion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ExpreS2ion Biotech's price. Additionally, you may evaluate how the addition of ExpreS2ion Biotech to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |